טוען...
Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19
To evaluate the efficacy and safety of a new treatment for COVID-19 vs. standard care, certain key endpoints are related to the duration of a specific event, such as hospitalization, ICU stay, or receipt of supplemental oxygen. However, since patients may die in the hospital during study follow-up,...
שמור ב:
| הוצא לאור ב: | Contemp Clin Trials |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7486285/ https://ncbi.nlm.nih.gov/pubmed/32927092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2020.106145 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|